JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kjems, E
Right arrow Articles by Henrichsen, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kjems, E
Right arrow Articles by Henrichsen, J
J Clin Microbiol. 1980 February; 11(2): 111-113

Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin.

E Kjems, B Perch and J Henrichsen

ABSTRACT

A total of 252 strains of group B streptococci were serotyped and examined for their ability to ferment lactose (lac+), to hydrolyze salicin (sal+), and to produce hyaluronidase (hy+). Of these strains, 67 had been isolated from bacteremia and meningitis in infants less than 2 months old. Eighty-one strains were isolated from bacteremia and meningitis in adults, and 104 strains were from various other infections. Type III was the most common in neonatal disease, especially if isolates from cases of bacteremia in infants less than 10 days of age were not included. Only 6% of the strains were lac+. Sal+/hy+ strains were never type III, but 91% of the strains belonging to the other serotypes were sal+/hy/. Results showed that 81% of the sal+/hy- strains and 95% of the sal-/hy+ strains were type III, and sal-/hy+ strains were more than twice as frequent as sal+/hy- strains in serious neonatal infections, in contrast to the other two disease groups, in which the opposite was found to be the case. These reactions may be used as additional markers in epidemiological studies.


J Clin Microbiol. 1980 February; 11(2): 111-113







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1980 by the American Society for Microbiology. All rights reserved.